These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34695768)

  • 1. Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3.
    Reynolds KE; Krasovska V; Scott AL
    J Neuroimmunol; 2021 Dec; 361():577745. PubMed ID: 34695768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte-mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome.
    Reynolds KE; Wong CR; Scott AL
    Glia; 2021 Jul; 69(7):1816-1832. PubMed ID: 33754385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IL-6 Secretion by Astrocytes via TLR4 in the Fragile X Mouse Model.
    Krasovska V; Doering LC
    Front Mol Neurosci; 2018; 11():272. PubMed ID: 30123107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile X syndrome.
    Yang Q; Feng B; Zhang K; Guo YY; Liu SB; Wu YM; Li XQ; Zhao MG
    PLoS Genet; 2012; 8(12):e1003172. PubMed ID: 23300470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model.
    Vandenberg GG; Dawson NJ; Head A; Scott GR; Scott AL
    Neurochem Int; 2021 Jun; 146():105036. PubMed ID: 33785420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
    Yuskaitis CJ; Beurel E; Jope RS
    Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of Mitochondrial Components from Extracellular Vesicles Secreted from Astrocytes in a Mouse Model of Fragile X Syndrome.
    Ha BG; Heo JY; Jang YJ; Park TS; Choi JY; Jang WY; Jeong SJ
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects.
    Vandenberg GG; Thotakura A; Scott AL
    Am J Physiol Cell Physiol; 2022 Feb; 322(2):C125-C135. PubMed ID: 34817267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
    Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
    Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide-induced inflammation leads to acute elevations in pro-inflammatory cytokine expression in a mouse model of Fragile X syndrome.
    Hodges SL; Nolan SO; Tomac LA; Muhammad IDA; Binder MS; Taube JH; Lugo JN
    Physiol Behav; 2020 Mar; 215():112776. PubMed ID: 31838149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic Signalling Mediates Aberrant Excitability of Developing Neuronal Circuits in the Fmr1 Knockout Mouse Model.
    Reynolds KE; Huang E; Sabbineni M; Wiseman E; Murtaza N; Ahuja D; Napier M; Murphy KM; Singh KK; Scott AL
    Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38652351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental Emergence of Phenotypes in the Auditory Brainstem Nuclei of
    Rotschafer SE; Cramer KS
    eNeuro; 2017; 4(6):. PubMed ID: 29291238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
    Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
    Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in insulin-like growth factor signaling alter phenotypes in Fragile X Mice.
    Wise TL
    Genes Brain Behav; 2017 Feb; 16(2):241-249. PubMed ID: 27643697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.
    Yang Q; Yang L; Zhang K; Guo YY; Liu SB; Wu YM; Li XQ; Song Q; Zhuo M; Zhao MG
    Ann Neurol; 2015 Apr; 77(4):618-36. PubMed ID: 25611593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.